BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 17988867)

  • 1. On the horizon: can bisphosphonates prevent bone metastases?
    Coleman R
    Breast; 2007 Dec; 16 Suppl 3():S21-7. PubMed ID: 17988867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates: reducing the risk of skeletal complications from bone metastasis.
    Costa L
    Breast; 2007 Dec; 16 Suppl 3():S16-20. PubMed ID: 18032044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging strategies in bone health management for the adjuvant patient.
    Coleman RE
    Semin Oncol; 2007 Dec; 34(6 Suppl 4):S11-6. PubMed ID: 18068485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal management of metastatic bone disease.
    Major P
    Eur J Oncol Nurs; 2007; 11 Suppl 2():S32-7. PubMed ID: 17804294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of bisphosphonate treatment in clinical practice.
    Aapro MS
    Semin Oncol; 2007 Dec; 34(6 Suppl 4):S28-32. PubMed ID: 18068488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging role of bisphosphonates in the clinic--antitumor activity and prevention of metastasis to bone.
    Lipton A
    Cancer Treat Rev; 2008; 34 Suppl 1():S25-30. PubMed ID: 18486347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical value of bisphosphonates in cancer therapy.
    Lüftner D; Henschke P; Possinger K
    Anticancer Res; 2007; 27(4A):1759-68. PubMed ID: 17649770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of bisphosphonates: promising preclinical evidence.
    Guise TA
    Cancer Treat Rev; 2008; 34 Suppl 1():S19-24. PubMed ID: 18486348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moving into the future: treatment of bone metastases and beyond.
    Hortobagyi GN
    Cancer Treat Rev; 2005; 31 Suppl 3():9-18. PubMed ID: 16249057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of bone disease.
    Kinnane N
    Eur J Oncol Nurs; 2007; 11 Suppl 2():S28-31. PubMed ID: 17768092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
    J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of bisphosphonates in cancer patients.
    Wu S; Dahut WL; Gulley JL
    Acta Oncol; 2007; 46(5):581-91. PubMed ID: 17562434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial.
    Cartenì G; Bordonaro R; Giotta F; Lorusso V; Scalone S; Vinaccia V; Rondena R; Amadori D
    Oncologist; 2006; 11(7):841-8. PubMed ID: 16880243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonate therapy for metastatic bone disease: the pivotal role of nurses in patient education.
    Fitch MI; Maxwell C
    Oncol Nurs Forum; 2008 Jul; 35(4):709-13. PubMed ID: 18591175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the nurse in preserving patients' independence.
    Maxwell C
    Eur J Oncol Nurs; 2007; 11 Suppl 2():S38-41. PubMed ID: 17768093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate therapy for patients with breast carcinoma.
    Plunkett TA; Rubens RD
    Cancer; 2003 Feb; 97(3 Suppl):854-8. PubMed ID: 12548586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of bone metastases with bisphosphonates].
    Gremaud M; Delouche D; Monnerat C
    Rev Med Suisse; 2006 Aug; 2(75):1861-6. PubMed ID: 16948423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of bone metastases in breast cancer patients.
    Petrut B; Simmons C; Broom R; Trinkaus M; Clemons M
    Expert Opin Pharmacother; 2008 Apr; 9(6):937-45. PubMed ID: 18377337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Too much, too little, too late to start again? Assessing the efficacy of bisphosphonates in patients with bone metastases from breast cancer.
    Clemons M; Dranitsaris G; Cole D; Gainford MC
    Oncologist; 2006 Mar; 11(3):227-33. PubMed ID: 16549806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New results from the use of bisphosphonates in cancer patients.
    Coleman R; Gnant M
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.